periodontal disease in type 1 Diabetes Mellitus Patients

Assessment of Periodontal status of Type 1 Diabetes Mellitus patients- A hospital based cross sectional study

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2018/04/013275

Enrollment

128

Registered

2018-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with type 1 Diabetes Melllitus

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA A. For T1DM Group 1. Patients diagnosed with T1DM at least 1 year before the time of periodontal status assessment 2. Patients above the age of 12. 3. Minimum of 20 teeth present B. For Control Group 1. Individuals above the age of 12. 2. Non diabetic systemically healthy individuals who are willing to sign informed consent 3. Minimum of 20 teeth present

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA A. For T1DM Group 1. Patients with other systemic diseases which may affect the periodontal status (Osteoporosis , Rheumatoid Arthritis etc), 2. pregnant and lactating mothers 3. Patients taking medications which may affect the periodontal status (Nifedipine, Cyclosporine, Phenytoin etc) 4. Patients with acute condition that contraindicate a periodontal examination. 5. Patients who received periodontal therapy past 1 year. 6. Patients not willing to sign informed consent B. For Control Group 1. Individuals who received systemic antibiotic therapy within past 6 month and periodontal therapy past 1 year. 2. Pregnancy 3. Lactating mothers

Design outcomes

Primary

Measure	Time frame
the proportion and severity of periodontal disease in T1DM patients as compared to control group.Timepoint: the primary outcome variable is assessed at a single point of time ( over the study period of 6 months)	—

Secondary

Measure	Time frame
whether any relation exist between the duration of T1DM, dosage of Insulin and periodontal disease severity.Timepoint: the secondary outcome variables are assessed at a single point of time ( over the study period of 6 months)	—

Countries

India

Contacts

Public ContactDr Rosamma Joseph V

Government dental college, kozhikode

drrosammajoseph@gmail.com9446070599

Outcome results